Simplex Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,000
| Closed | -$29K | – | 10647 |
|
|
2022
Q4 | $29K | Sell |
5,000
-1,900
| -28% | -$9.99K | ﹤0.01% | 6530 |
|
|
2022
Q3 | $46K | Sell |
6,900
-5,800
| -46% | -$35.2K | ﹤0.01% | 6577 |
|
|
2022
Q2 | $53K | Buy |
+12,700
| New | +$50.3K | ﹤0.01% | 6430 |
|
|
2021
Q4 | – | Sell |
-2,000
| Closed | -$8K | – | 11782 |
|
|
2021
Q3 | $8K | Hold |
2,000
| – | – | ﹤0.01% | 9086 |
|
|
2021
Q2 | $8K | Buy |
2,000
+1,801
| +905% | +$7.62K | ﹤0.01% | 9260 |
|
|
2021
Q1 | $99K | Buy |
199
+151
| +315% | +$1.22K | ﹤0.01% | 5767 |
|
|
2020
Q4 | $60K | Buy |
48
+12
| +33% | +$137 | ﹤0.01% | 5996 |
|
|
2020
Q3 | $35K | Hold |
36
| – | – | ﹤0.01% | 5948 |
|
|
2020
Q2 | $35K | Buy |
36
+34
| +1,700% | +$326 | ﹤0.01% | 5806 |
|
|
2020
Q1 | $1K | Buy |
+2
| New | +$20 | ﹤0.01% | 7448 |
|
|
2019
Q3 | – | Sell |
-4
| Closed | -$4K | – | 8095 |
|
|
2019
Q2 | $4K | Sell |
4
-4
| -50% | -$43 | ﹤0.01% | 6582 |
|
|
2019
Q1 | $9K | Buy |
+8
| New | +$118 | ﹤0.01% | 6240 |
|
|
2018
Q3 | – | Sell |
-9
| Closed | -$15K | – | 8288 |
|
|
2018
Q2 | $15K | Sell |
9
-29
| -76% | -$563 | ﹤0.01% | 6099 |
|
|
2018
Q1 | $2K | Buy |
38
+21
| +124% | +$467 | ﹤0.01% | 5406 |
|
|
2017
Q4 | $1K | Sell |
17
-133
| -89% | -$2.68K | ﹤0.01% | 5725 |
|
|
2017
Q3 | $3K | Buy |
150
+50
| +50% | +$726 | ﹤0.01% | 4907 |
|
|
2017
Q2 | $6K | Sell |
100
-13
| -12% | -$192 | ﹤0.01% | 4491 |
|
|
2017
Q1 | $39K | Buy |
113
+100
| +769% | +$1.2K | ﹤0.01% | 2608 |
|
|
2016
Q4 | $7K | Buy |
+13
| New | +$119 | ﹤0.01% | 4112 |
|
|
2016
Q2 | – | Sell |
-64
| Closed | -$1K | – | 6641 |
|
|
2016
Q1 | $1K | Buy |
64
+30
| +88% | +$432 | ﹤0.01% | 5293 |
|
|
2015
Q4 | $4K | Buy |
+34
| New | +$739 | ﹤0.01% | 4093 |
|
Simplex Trading's CNCE Position: Q1 2023 in Review
Simplex Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 5,789 shares — an estimated $33K sold.
Simplex Trading first reported a position in CNCE in Q4 2015 and held it in 20 quarters. The position peaked at $222K in Q3 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Simplex Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 5,789 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $33K.
- Simplex Trading first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 20 quarters.
- Simplex Trading's Concert Pharmaceuticals, Inc. position peaked at $222K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.